6 January 2020
Campaigners push for drug companies to give greater access to TB treatments.
Eswatini, formerly Swaziland, has halved the number of recorded cases of tuberculosis (TB), according to the World Health Organisation (WHO). The country, one of the few to have exceeded the 70% target for detection of infectious TB, is set to reach 85% treatment success the WHO says. Eswatini’s government has been implementing several interventions focusing on testing and streamlining drug supply systems with the support of international partners. The government added that the improved collection of samples from people suspected of having TB, along with improved diagnosis have contributed to the improvement in TB treatment.
At the same time Médecins Sans Frontières, the international medical non-governmental organisation, along with other groups, are pressuring international drug manufacturers to make drug-resistant TB treatment affordable and more readily available to patients worldwide. Campaigners say that there are three new drugs that can offer an improved chance of being cured.
For more on this visit C&I
- SCI's Fine Chemicals Group
- Research unpicks antibiotic resistance
- Pharmaceutical leaders kick off CPhI 2018 in closed-door session